Slingshot members are tracking this event:

Novartis (NVS) Announces FDA Approval for Expanded Use of Illaris in Periodic Fever Syndrome Conditions

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks

Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 23, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Fda Approval, Expanded Use, Ilaris, Periodic Fever Syndrome Conditions